Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
NCT00286416
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Allergic Rhinitis
Interventions
DRUG:
omalizumab (Xolair)
Sponsor
Scripps Clinic